Bio
Dhruv Khurana is a senior economist at UCLA's David Geffen School of Medicine who works on evaluating the causal impact of pivotal SUD healthcare policies for the State of California. His investigations delve into the transformative effects of initiatives like the CA 1115/DMC-ODS waiver, Naloxone Distribution Program, and Prop 64, focusing on their implications for overdose rates, overdose deaths, and treatment access for marginalized populations. Additionally, his impactful work involves designing, implementing, and evaluating the groundbreaking Whole PERSON Health Score. By quantifying and highlighting Social Determinants of Health, this holistic assessment tool empowers care teams to execute timely, targeted interventions. The paper was honored as the New England Journal of Medicine Catalyst Editors' Pick of the Year 2022 and recognized by the Centers for Disease Control and Prevention (CDC) in their Science-in-Action brief. Dhruv's dedication to diversity and excellence earned him the title of "Diversity Scholar" from the American Society of Health Economists (ASHE) in 2020. In addition, he has been recognized as the "Most Valued Professor" for three consecutive years at California State University. Dhruv Khurana holds a PhD in Economics, specializing in Health Economics and Econometrics, and an MA in Economics, with a concentration in Behavioral and Neuroeconomics, both from Claremont Graduate University and an MS in Finance from the London School of Economics.